Quanta has developed an advanced haemodialysis system for use in the
home and clinic. Our proprietary cartridge-based system, SC+, is a
portable and compact providing clinical efficacy utilising high flow
rates typically used on traditional machines. SC+ is designed to offer
ease-of-use and flexibility, facilitating self-care and supporting
dialysis patients across the entire continuum of care.
Quanta is privately owned and based in Alcester, UK. The Company was
founded in 2008 as a spin out from the FTSE 100 engineering company IMI
plc, with funding provided by a group of leading venture capital
investors specialised in healthcare: Air Liquide, b-to-v Partners AG,
IMI, Kuwait Life Sciences Company, NBGI Ventures, Seroba Kernel
LifeSciences, Seventure Partners and Wellington Partners.
Latest funding size
Time since last funding
|over 1 year|
|Wellington Partners, b-to-v Partners AG, Seroba Kernel, NBGI Ventures, National Institute for Health Research|